RMD Q2 2025 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena

RMDResMed Inc.

$36B

Q2 2025 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$1.3B+10.3% YoY

Gross Profit

$751M58.6% margin

Operating Income

$417M32.5% margin

Net Income

$345M26.9% margin

EPS (Diluted)

$2.34

QoQ Revenue Growth

+4.7%

Cash Flow

Operating Cash Flow

$309M

Free Cash Flow

$290M

Stock-Based Comp.

$23M

Balance Sheet

Total Assets

$7.1B

Total Liabilities

$1.9B

Stockholders' Equity

$5.3B

Cash & Equivalents

$522M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.3B	$1.2B	+10.3%
Gross Profit	$751M	$669M	+12.2%
Operating Income	$417M	$275M	+51.7%
Net Income	$345M	$209M	+65.0%

Revenue Segments

Sleep And Respiratory

$1.1B88%

Residential Care Software

$156M12%

Geographic Segments

Us Canada And Latin America

$749M58%

Combined Europe Asia And Other Markets

$377M29%

Global

$156M12%